tiprankstipranks
Trending News
More News >
ReShape Lifesciences (RSLS)
NASDAQ:RSLS
US Market

ReShape Lifesciences (RSLS) Ratios

Compare
530 Followers

ReShape Lifesciences Ratios

RSLS's free cash flow for Q4 2024 was $0.73. For the 2024 fiscal year, RSLS's free cash flow was decreased by $ and operating cash flow was $-0.36. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.92 2.73 1.32 4.13 0.77
Quick Ratio
0.43 1.74 0.84 3.72 0.58
Cash Ratio
0.14 1.18 0.52 3.11 0.25
Solvency Ratio
-1.41 -2.81 -5.89 -7.32 -0.88
Operating Cash Flow Ratio
-0.89 -4.49 -2.93 -2.10 -0.74
Short-Term Operating Cash Flow Coverage
-4.78 0.00 -128.08 -55.11 -2.37
Net Current Asset Value
$ -458.00K$ 6.30M$ 2.43M$ 22.07M$ -13.63M
Leverage Ratios
Debt-to-Assets Ratio
0.20 0.02 0.02 <0.01 0.01
Debt-to-Equity Ratio
-3.82 0.04 0.05 <0.01 0.03
Debt-to-Capital Ratio
1.35 0.04 0.04 <0.01 0.03
Long-Term Debt-to-Capital Ratio
-0.19 0.00 0.00 0.00 0.39
Financial Leverage Ratio
-18.94 1.60 3.04 1.18 2.56
Debt Service Coverage Ratio
-7.24 0.00 -86.43 -54.47 -3.17
Interest Coverage Ratio
0.00 0.00 -239.63 -33.35 -6.08
Debt to Market Cap
0.42 0.00 0.06 0.02 0.73
Interest Debt Per Share
1.88 2.55 38.81 294.88 1.88K
Net Debt to EBITDA
-0.04 0.29 0.15 0.37 0.14
Profitability Margins
Gross Profit Margin
63.17%63.93%60.52%61.38%55.42%
EBIT Margin
-83.29%-168.69%-240.91%-460.21%-174.90%
EBITDA Margin
-83.29%-166.92%-221.75%-445.71%-160.15%
Operating Profit Margin
-83.29%-168.69%-240.91%-204.04%-110.25%
Pretax Profit Margin
-88.57%-130.62%-414.54%-456.17%-193.03%
Net Profit Margin
-89.06%-131.22%-411.16%-455.39%-191.43%
Continuous Operations Profit Margin
-89.06%-131.22%-411.16%-464.31%-191.43%
Net Income Per EBT
100.55%100.46%99.18%99.83%99.17%
EBT Per EBIT
106.34%77.43%172.07%223.57%175.09%
Return on Assets (ROA)
-148.76%-106.79%-414.77%-114.15%-58.36%
Return on Equity (ROE)
2818.18%-170.90%-1262.33%-134.43%-149.30%
Return on Capital Employed (ROCE)
3472.92%-212.59%-739.63%-59.13%-48.94%
Return on Invested Capital (ROIC)
-913.44%-210.18%-670.93%-58.34%-42.05%
Return on Tangible Assets
-148.76%-106.79%-424.68%-185.26%-215.46%
Earnings Yield
-310.08%-765.73%-1615.65%-345.63%-123.10%
Efficiency Ratios
Receivables Turnover
8.11 5.23 5.16 4.83 4.31
Payables Turnover
1.34 1.85 2.30 1.51 1.38
Inventory Turnover
1.20 0.84 1.23 1.75 2.24
Fixed Asset Turnover
51.99 27.99 12.93 7.91 10.77
Asset Turnover
1.67 0.81 1.01 0.25 0.30
Working Capital Turnover Ratio
2.62 1.94 0.89 1.34 -7.68
Cash Conversion Cycle
76.19 309.07 209.37 43.23 -17.61
Days of Sales Outstanding
45.00 69.78 70.79 75.55 84.64
Days of Inventory Outstanding
304.48 436.25 296.98 208.70 162.61
Days of Payables Outstanding
273.29 196.96 158.40 241.02 264.86
Operating Cycle
349.47 506.03 367.78 284.25 247.24
Cash Flow Ratios
Operating Cash Flow Per Share
-8.59 -165.14 -2.99K -4.08K -6.35K
Free Cash Flow Per Share
-8.59 -165.56 -3.01K -4.17K -6.64K
CapEx Per Share
0.00 0.42 17.90 93.43 289.65
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.01 1.02 1.05
Dividend Paid and CapEx Coverage Ratio
0.00 -394.42 -167.19 -43.68 -21.92
Capital Expenditure Coverage Ratio
0.00 -394.42 -167.19 -43.68 -21.92
Operating Cash Flow Coverage Ratio
-4.58 -64.73 -128.08 -55.11 -17.92
Operating Cash Flow to Sales Ratio
-0.55 -1.95 -1.95 -1.13 -0.76
Free Cash Flow Yield
-192.53%-1143.38%-770.28%-87.77%-50.88%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.32 -0.13 -0.06 -0.29 -0.81
Price-to-Sales (P/S) Ratio
0.29 0.17 0.25 1.32 1.56
Price-to-Book (P/B) Ratio
-9.09 0.22 0.78 0.39 1.21
Price-to-Free Cash Flow (P/FCF) Ratio
-0.52 -0.09 -0.13 -1.14 -1.97
Price-to-Operating Cash Flow Ratio
-0.52 -0.09 -0.13 -1.17 -2.06
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Price-to-Fair Value
-9.09 0.22 0.78 0.39 1.21
Enterprise Value Multiple
-0.39 0.19 0.03 0.08 -0.83
EV to EBITDA
-0.39 0.19 0.03 0.08 -0.83
EV to Sales
0.32 -0.31 -0.07 -0.34 1.34
EV to Free Cash Flow
-0.58 0.16 0.04 0.29 -1.69
EV to Operating Cash Flow
-0.58 0.16 0.04 0.30 -1.77
Tangible Book Value Per Share
-0.49 64.88 464.80 6.70K -9.31K
Shareholders’ Equity Per Share
-0.49 64.88 500.34 12.23K 10.76K
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 <0.01 <0.01 <0.01
Revenue Per Share
15.53 84.50 1.54K 3.61K 8.39K
Net Income Per Share
-13.83 -110.88 -6.32K -16.44K -16.06K
Tax Burden
1.01 1.00 0.99 1.00 0.99
Interest Burden
1.06 0.77 1.72 0.99 1.10
Research & Development to Revenue
0.23 0.27 0.23 0.19 0.31
SG&A to Revenue
0.87 1.19 1.53 1.79 0.93
Stock-Based Compensation to Revenue
0.02 0.09 0.19 0.90 0.12
Income Quality
0.62 1.49 0.47 0.25 0.40
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis